Results 181 to 190 of about 24,978 (221)

Primary treatment of chronic pulmonary aspergillosis with weekly liposomal amphotericin B: A case report from Uganda. [PDF]

Med Mycol Case Rep
Kibone W, Bongomin F, Denning DW, Meya DB.   +3 more
europepmc   +1 more source

Clinical applications of immunoglobulin G against different individual Aspergillus species for the diagnosis of chronic pulmonary aspergillosis among at-risk populations. [PDF]

Pathog Glob Health
Keng LT, Lin CC, Wu CW, Liu CJ, Chang LY, Lee MR, Chen JY, Wang JY.   +7 more
europepmc   +1 more source

[Chronic necrotizing pulmonary aspergillosis].

Pneumonologia i alergologia polska, 2000
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pulmonary TB and chronic pulmonary aspergillosis

The International Journal of Tuberculosis and Lung Disease, 2021
BACKGROUND: Pulmonary TB (PTB) and chronic pulmonary aspergillosis (CPA) are both progressive and debilitating parenchymal lung diseases with overlapping risk factors, symptomatology and radiological findings that often result in misdiagnosis of either disease.METHODS: We undertook a narrative review approach to describe the clinical and radiological ...
R, Sarda, A, Ray
openaire   +4 more sources

Chronic Necrotizing Pulmonary Aspergillosis*

Chest, 1997
Joseph L. Saraceno, Douglas T. Phelps, Thomas J. Ferro, Ross Futerfas, Douglas B. Schwartz   +4 more
openaire   +3 more sources

Chronic pulmonary aspergillosis

Mycoses, 2013
SummaryChronic pulmonary aspergillosis (CPA) is a group of consuming diseases usually presenting with prolonged and relapsing cough, dyspnoea and weight loss. Acute symptoms such as haemoptysis and bronchial or pulmonary haemorrhage may occasionally occur.
K E, Schweer, C, Bangard, K, Hekmat, O A, Cornely   +3 more
openaire   +2 more sources

Chronic Pulmonary Aspergillosis

Seminars in Respiratory and Critical Care Medicine, 2023
Chronic pulmonary aspergillosis (CPA) refers to a number of clinical syndromes resulting from the presence and local proliferation of Aspergillus organisms in the lungs of patients with chronic lung disease. CPA is more common than was realized two decades ago.
Evans, Terry J., Lawal, Abdul Azeez, Kosmidis, Chris, Denning, David W.   +3 more
openaire   +1 more source

Management of chronic pulmonary aspergillosis

Annals of the New York Academy of Sciences, 2012
Chronic pulmonary aspergillosis (CPA) is a relatively rare, slowly progressive pulmonary syndrome caused by Aspergillus spp. The scarcity of clinical evidence for its management is an important issue. Oral azoles are recommended as the primary treatment of CPA; however, the evidence for their effectiveness is insufficient. Azole‐resistant A.
Koichi, Izumikawa, Masato, Tashiro, Shigeru, Kohno   +2 more
openaire   +2 more sources

Imaging Spectrum in Chronic Pulmonary Aspergillosis

The American Journal of Tropical Medicine and Hygiene, 2023
ABSTRACT. Chronic pulmonary aspergillosis (CPA) is a life-threatening respiratory fungal infection that is almost exclusively seen in patients with preexisting structural lung disease with no or mild immunosuppression. The clinical presentation and imaging findings are varied and often pose a diagnostic challenge; and the disease is often present for a
Mandeep, Garg, Harsimran, Bhatia, Tany, Chandra, Uma, Debi, Inderpaul Singh, Sehgal, Nidhi, Prabhakar, Manavjit Singh, Sandhu, Ritesh, Agarwal   +7 more
openaire   +2 more sources

Chronic pulmonary scedosporiosis simulating aspergillosis

Respirology, 2005
Abstract:  Scedosporium apiospermum, a ubiquitously distributed saprophyte, is emerging as an important pathogen in immunocompromised patients. We describe a 72‐year‐old patient with chronic S. apiospermum infection of the lung simulating aspergilloma.
Takeharu, Koga, Takao, Kitajima, Reiko, Tanaka, Masashi, Hirokawa, Masao, Ichiki, Toru, Rikimaru, Hisamichi, Aizawa   +6 more
openaire   +2 more sources